Clinical Trial Update: Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial DIAMOND evaluating patiromer for managing hyperkalemia in patients on RAAS inhibitors for heart failure has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hyperkalemia

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Vifor Pharma, Inc. | Conditions: Hyperkalemia | Phase 3 | Status: COMPLETED | Results posted: 2023-02-24